Clinical Trial Update: SB1518 for Patients With Myelodysplastic Syndrome (MDS) [Phase 2]

View source ↗

Summary

This update reports Phase 2 results for SB1518 in patients with myelodysplastic syndrome (MDS); the trial was terminated and results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• SB1518

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2016-06-15